biomedicines
Opinion
Quiescence-Origin Senescence: A New Paradigm in
Cellular Aging
GuangYao1,2
1 DepartmentofMolecular&CellularBiology,UniversityofArizona,Tucson,AZ85721,USA;
guangyao@arizona.edu
2 ArizonaCancerCenter,UniversityofArizona,Tucson,AZ85719,USA
Abstract:Cellularsenescence,traditionallyviewedasaconsequenceofproliferatingandgrowing
cellsoverwhelmedbyextensivestressesanddamage,haslongbeenrecognizedasacriticalcellular
agingmechanism. Recentresearch,however,hasrevealedanovelpathwaytermed“quiescence-
originsenescence”,wherecellsdirectlytransitionintosenescencefromthequiescentstate,bypassing
cellproliferationandgrowth.Thisopinionpaperpresentsaframeworkconceptualizingacontinuum
betweenquiescenceandsenescencewithquiescencedeepeningasaprecursortosenescenceentry.
Weexplorethetriggersandcontrollersofthisprocessanddiscussitsbiologicalimplications.Given
thatthemajorityofcellsinthehumanbodyaredormantratherthanproliferative,understanding
quiescence-originsenescencehassignificantimplicationsfortissuehomeostasis,aging,cancer,and
variousdiseaseprocesses.Thenewparadigminexploringthispreviouslyoverlookedsenescentcell
populationmayreshapeourinterventionstrategiesforage-relateddiseasesandtissueregeneration.
Keywords: quiescence; senescence; quiescence deepening; dormancy state continuum; Rb–E2F
switchthreshold;geroconversion
1. Introduction
Cellular senescence, a state of permanent cell cycle arrest, has been a focal point
of biomedical research for decades [1]. It is typically triggered when growing cells are
Citation:Yao,G.Quiescence-Origin
overwhelmed by extensive stresses and damage, such as telomere erosion, oncogene
Senescence:ANewParadigmin
activation,oxidativestress,andDNAdamage,toadegreebeyondtheirrepaircapacity[2,3].
CellularAging.Biomedicines2024,12,
Cellsentersenescenceandpermanentlyhaltproliferationtoavoiddeleteriousconsequences
1837. https://doi.org/10.3390/
likemalignanttumorigenesisandfibroticresponse[4,5]. Thehallmarksofsenescentcells
biomedicines12081837
includepermanentcellcyclearrest, senescence-associatedsecretoryphenotype(SASP),
AcademicEditors:FrancescaFaggioli macromolecular damage, deregulated metabolism [6], and often enlarged cell size and
andKarenCrasta othermorphologicalchanges[2,7]. Thisconventionalviewhasshapedourunderstanding
ofsenescenceprimarilyasanextremestressresponseinproliferatingandgrowingcells.
Received:30July2024
Incontrast,cellularquiescenceisareversiblestateofcellcyclearrest. Underphysio-
Revised:3August2024
logicalgrowth-limitingconditions,suchasmitogenwithdrawalorcontactinhibition,cells
Accepted:9August2024
Published:13August2024 exitthecellcycleandenterquiescence[8]. Quiescentcellsaretypicallyassociatedwithlow
metabolicactivityandreducedcellsizeanddonotexhibitobviousdeleteriousphenotypes
associatedwithsenescence,suchasSASPandseveredamage[8,9]. Uponrestorationof
growth-permissive conditions (e.g., reintroducing growth factors or alleviating contact
Copyright: © 2024 by the author. inhibition),quiescentcellscanresumeproliferation,whichisakeydistinctionfromsenes-
Licensee MDPI, Basel, Switzerland. centcells[8,9]. Quiescenceisconsideredaphysiologicalstatethatallowscellstomaintain
Thisarticleisanopenaccessarticle cellular viability and integrity under growth-limiting conditions, playing a crucial role
distributed under the terms and intissuehomeostasisandstemcellmaintenance[9,10]. Thismechanismisproposedto
conditionsoftheCreativeCommons
safeguardcellsfromsenescence[11,12].
Attribution(CCBY)license(https://
Recentresearchinthepastdecade,however,hasbeguntochallengethistraditional
creativecommons.org/licenses/by/
paradigmbydemonstratingthatsenescencecanoriginatedirectlyfromquiescentcellsin
4.0/).
Biomedicines2024,12,1837.https://doi.org/10.3390/biomedicines12081837 https://www.mdpi.com/journal/biomedicines
Biomedicines2024,12,1837 2of8
variouscontexts[13–16].Thisphenomenon,whichweterm“quiescence-originsenescence”,
suggestsafluidcontinuumbetweenquiescenceandsenescencewithprofoundimplications
fortissuehomeostasis,aging,anddiseaseprocesses. Notably,proliferatingcellsaccount
forlessthan1%ofthethirty-seventrillioncellsinthehumanbodyatanygiventime[17],
suggestingthatquiescence-originsenescencemayunderliealargeproportionofpreviously
overlookedormisclassifiedsenescentcells.
This brief review synthesizes recent findings to provide a new framework for un-
derstandingsenescencefromtheperspectiveofcelldormancy–stateplasticity,aimingto
stimulatefurtherrelatedresearchintonovelinterventionstrategiesforage-relateddiseases,
cancer,andregenerativemedicine.
2. TheQuiescence–SenescenceContinuum: AFrameworkforUnderstanding
Quiescence-OriginSenescence
2.1. DirectTransitionfromQuiescencetoSenescence
Mountingevidenceinthepastdecadedemonstratesadirecttransitiontosenescencein
quiescentcellsunderstressorwithaging. Oneofthefirstreportsofthisphenomenonwas
ingeriatricmice,wherequiescentsatellitecells(musclestemcells,MuSCs)loseregenerative
capacityandbecomeirreversiblyarrested[13]. Thesameobservationwasconfirmedin
geriatrichumanmuscle,suggestingaconservedmechanismcontributingtoage-related
declineinmuscleregenerativecapacity[13]. Thequiescence-to-senescencetransitionin
geriatric MuSCs was linked to the epigenetic derepression of p16INK4a, which is a key
regulatorofsenescence[13].
Furtherresearchrevealedthatp16INK4aderepressioningeriatricMuSCswastriggered
byaccumulatedreactiveoxygenspecies(ROS)resultingfromfailedautophagy[18]. Restor-
ingautophagypreventsthetransitiontosenescenceinquiescentMuSCs[18]. Similarly,
in quiescent human hematopoietic stem progenitor cells (HSPCs), stress-induced ROS
accumulationcanelevatethep16INK4alevelanddrivethetransitiontosenescence[14].
Invitrostudiesprovidefurtherevidenceforthedirectquiescence-to-senescencetran-
sition. Long-termquiescenthumanfibroblastsinculture(100–150days)accumulateDNA
damage and transit into senescence [15]. Our recent work showed that quiescent rat
embryonic fibroblasts (REFs) with impaired lysosomal autophagy can directly enter a
senescence-likestatecharacterizedbyirreversiblecellcyclearrest,β-galactosidaseactivity,
and cellular hypertrophy [16]. These invitro results strengthen the findings of invivo
studiesbyshowingthatcellsmaintainedinquiescentconditionsthroughouttheexperi-
mentseventuallytransitionedtosenescence,bypassingcellproliferation(whichcanbe
difficulttotrackinvivo,e.g.,throughouttheentiregeriatricphase). Together,theseinvivo
andinvitrostudiesprovidecompellingevidenceforthedirectquiescence-to-senescence
transition,resultinginquiescence-originsenescence.
2.2. QuiescenceDeepeningintoSenescence: AContinuumModel
Theobservationthatcellscantransitionfromquiescencetosenescencealignswiththe
conceptthatquiescenceisnotauniformstatebutratheraspectrumofdormantdepths.
Specifically,deeperquiescentcellsaremoreresistanttocellcyclere-entry,andtheyresume
proliferationlessfrequentlyorwithalongerdelaythanshallowerquiescentcellsgiventhe
samegrowthstimulation[8,19–35]. Cellsindeepquiescencegenerallyexhibitdecreased
transcription, reduced RNA and protein levels, and increased chromatin condensation
comparedtocellsinshallowquiescence[22,36–38].Recentstudieshavefurtherrevealedthe
changesinthecellularprofilesofgeneexpression,epigeneticmodification,andmetabolism
thatoccurduringtheprocessofquiescencedeepening[8,16,39–41]. Itisimportanttonote
thatdeepquiescentcells,bydefinition,stillretainthepotentialforcellcyclere-entryand
canresumeproliferationgivenasufficientlystrongandsustainedgrowthstimulus,which
isdistinctfromsenescentcells.
Quiescencedeepeninghasbeenobservedunderextendedquiescenceincultureor
alongtheagingprocessinvivoacrossmammaliancelltypesandtissues[8,19–33]aswell
Biomedicines2024,12,1837 3of8
asinyeast[34]andC.elegans[35]. Consistentwithquiescencedepthbeingacontinuum,
subpopulations of quiescent muscle, neural, and hematopoietic stem cells, upon tissue
injury orin response tosystemic factors, can moveto shallower (primedor G ) qui-
Alert
escence, bearing a closer resemblance to activecells [42–45]. Further extending thecell
dormancystatecontinuum,senescentcellsalsoexhibitvarying“depths”withdifferent
cellularcharacteristics[46–48].
Ourrecentworkdirectlylinksquiescencedeepeningtosenescenceentry. Wefound
thatwhileenhancinglysosomalautophagyactivitypushesREFstowardshallowquiescence,
decreasinglysosomalautophagydrivesREFsintoprogressivelydeeperquiescence[16].
Whenlysosomalautophagyisseverelyhampered(withchloroquinetreatment,forexam-
ple),deepquiescent(yetstillreversible)cellstransitionintoirreversiblesenescence[16].
Thissuggeststhatlysosomalautophagyactivityactsasa“dimmerswitch”thatcontinu-
ouslyadjustscellulardormancydepthfromshallowquiescencetodeepquiescenceand
finallytosenescence[16,41]. Furthermore,thetranscriptomicprofilechangesduringqui-
escence deepening in REFs resemble those of senescence entry with similar expression
changes in “senescence core signature” genes [16,49]. A gene signature derived from
quiescencedeepeninginREFs,thequiescencedepthscore(QDS),cancorrectlypredicta
widearrayofsenescentandagingcelltypes[16,50]. Together,thesefindingssuggestthat
quiescencedeepeningrepresentsacontinuumtransitiontrajectoryfromproliferationto
senescence,whichisamodelincreasinglyrecognizedinthefield[9,51–55].
Supporting the quiescence–senescence continuum concept, the levels of multiple
widelyusedsenescencebiomarkers(e.g.,SA-β-gal,LAMP1,IL8,53BP1,p21,LaminB1,and
cellsize)werefoundtoincreasegraduallywiththedurationofcell-cyclewithdrawaland
cannotdistinguishsenescencefromdeepquiescence[56]. Thisquiescence–senescencecon-
tinuumcouldhelpexplainsomenormalphysiologicalfunctionsofcellularsenescence[57],
assomeofthesenescentcellsidentifiedbasedonbiomarkerintensitiesmayinsteadbe
deepquiescentcells.
3. MechanismsUnderlyingQuiescenceDeepeningandQuiescence-OriginSenescence
Thecellularprocessesunderlyingquiescencedeepeningandtransitiontosenescence
likely involve a complex interplay between various cellular mechanisms and signaling
pathways. Yet,aconvergingthemehasstartedtoemergefromrecentstudies.
3.1. Trigger: TheLysosome–AutophagyAxis
Thelysosome–autophagyaxishasemergedasacriticaldriverofquiescencedeepening
andtransitiontosenescenceacrossvariouscelltypes.Autophagyinvolvesautophagosomes
engulfing cellular components and fusing with lysosomes, where lysosomal enzymes
degradethecontentsandrecyclethemacromolecules. Thislysosome–autophagyactivity
acts as a “dimmer switch” regulating quiescence depth in REFs with its continuously
decreasedactivityleadingtoprogressivelydeeperquiescencetowardsenescence[16]. It
alsounderliesthequiescence-to-senescencetransitioningeriatricMuSCs[18].
InbothREFsandgeriatricMuSCs,ROSaccumulationservesasakeyeffectoroftheim-
pairedlysosomalautophagyfunction[16,18]. InREFs,ROSaccumulation,withoutevoking
p16INK4a,leadstoquiescencedeepening[16];inMuSCs,ROSaccumulationepigenetically
derepressesthep16INK4a locusandleadstothequiescence-to-senescencetransition[18].
Similarly,ROSaccumulationdrivesthequiescence-to-senescencetransitioninHSPCsby
elevatingthep16INK4alevel[14].
In neural stem cells (NSCs), the lysosome–autophagy axis, with increased protein
aggregates as the main effector, plays a crucial role in quiescence deepening. Aging
quiescentNSCsdisplaylysosomaldefects,increasedproteinaggregates,anddiminished
activationpotential[58].
Enhancinglysosomalautophagyinvariouscelltypes,includingREFs,MuSCs,and
NSCs, promotes shallow quiescence away from the transition to senescence [16,18,58].
Biomedicines2024,12,1837 4of8
Together,thefindingsabovehighlightthelysosome–autophagyaxisasacentraltriggerof
quiescencedeepeningandthequiescence-to-senescencetransition.
3.2. Controller: TheRb–E2FSwitchThreshold
OurearlierstudiesdemonstratedthattheRb–E2Fpathway,apivotalregulatorofthe
cellcycleinanimalsandplants[59–63],functionsasabistabletoggleswitch[64,65]. This
Rb–E2F switch converts graded and transient mitogen signals into a binary (OFF/ON)
activityofE2F(representingthecombinedE2Ftranscriptionalactivators,E2F1-3a),which
underliestheall-or-nonequiescence-to-proliferationtransition[27,64,65]. Theactivation
threshold of the Rb–E2F switch, “Rb–E2F switch threshold” for short, controls quies-
cencedepth: increasingordecreasingthisthresholddrivescellstodeeperandshallower
quiescence, respectively [27,28,66]. The Rb–E2F switch threshold is defined as the min-
imumgrowthstimulusrequiredtoactivatethecellularE2Fleveltoexceedthatofnon-
phosphorylatedRb,whichbindstoandinhibitsE2Finquiescentcells[27,28,66]. Wehave
shown that the Rb–E2F switch threshold can be modulated by multiple factors in the
Rb–E2FpathwaywithvaryingdegreesofsensitivitywiththoseassociatedwithG1cyclins
andcyclin-dependentkinases(CDK)beingthemostprominent[28].
TheRb–E2Fswitchisthefirstbistableswitchthatcellsencounterduringthetransition
fromquiescencetoproliferationinresponsetomitogens,anditconnectstodownstream
bistableswitchesandcheckpointsregulatingSphaseentry[67,68]. GiventhattheRb–E2F
pathwayinteractswithotherquiescenceregulatorypathways(e.g.,Notch–Hes1,p53–p21,
PI3K–Akt,DNAdamageresponse,LKB1–AMPK,andmicroRNA)[10,27,63],wepropose
thattheRb–E2Fswitchservesasacorehubthatintegratescellularsignalstoquantitatively
determinethegrowthstimulationlevelrequiredfortheall-or-nonecellcyclere-entry. In
parallel,othercellularpathwaysimpingeontheRb–E2Fswitchandmodulateitsswitch
threshold. Thismodulatoryeffectmayoccurthroughcrosstalkwithvariousgenenodesin
theRb–E2Fswitchnetwork,mosteffectivelybyaffectingG1cyclinandCDKactivitiesin
thecell[13,28,69]. Higherthresholdsleadtodeeperquiescenceand,eventually,senescence
whenphysiologicalgrowthsignalscannolongerovercomethethreshold[27,41].Therefore,
thedifferencebetweendeepquiescenceandsenescenceliesprimarilyinthemagnitudeof
theRb–E2Fswitchthresholdratherthaninfundamentallydistinctcellularcharacteristics,
aligningwiththequiescence–senescencecontinuummodel.
The lysosomal–autophagy axis discussed above driving quiescence-to-senescence
transitioninMuSCsdirectlyincreasestheRb–E2Fswitchthreshold(byactivatingp16that
inhibitsCDKactivity)[13,18]. Similarly,increasingtheRb–E2Fswitchthresholdhasbeen
reportedtodrivedeepquiescenceinMuSCsviafasting-inducedketonebodysignaling(by
increasingp21thatinhibitsCDK)[69]. Thisthresholdmechanismpredictsapotentialway
toreversethe“irreversible”senescencebyreducingtheRb–E2Fswitchthreshold. Indeed,
studieshaveshownthatsenescentcellscanbereactivatedassuch,e.g.,byinactivatingRb,
p53–p21,orp16activities[70–75]orbytheforcedG1cyclinupregulation[76].
3.3. RemainingUnknownsandtheHeterogeneityinQuiescence-OriginSenescence
Severalkeyareasremaintobeexplored. TheroleofmTORsignaling,forinstance,
presentsanintriguingparadox. mTORisamajordriverofproliferation-originsenescence,
underlyingtheprocessofgeroconversion—aprocessinwhichmTOR-drivencellgrowth
continuesaberrantlyafterthecellcycleisblocked(e.g.,byCDKinhibitorsp21CIP1/Waf1and
p16INK4a)[11,77]. Inquiescence,mTORisinactiveandcellslacksustainedgrowth,which
hasbeenproposedasamechanismtoprotectquiescentcellsagainstsenescence[11,77].This
questionstheinvolvementofmTORinquiescencedeepeningandthequiescence-origin
senescence,whichalignswiththefactthatmTORactivityislinkedtoshallowquiescence
(G )[42],notquiescencedeepening.Therefore,thequiescence-originsenescenceappears
Alert
differentfromproliferation-originsenescencefromtheaspectofmTORandgeroconversion
(Figure1).
Biomedicines2024,12,1837 5of8
Biomedicines 2024, 12, x FOR PEER REVIEW 6 of 9
Figure1.Quiescence-originsenescence.Conventionalsenescenceoriginatesfromproliferatingand
Figure 1. Quiescence-origin senescence. Conventional senescence originates from proliferating and
ggrorwoiwng icnelgls vciae mllTsOvRi-amemdiaTteOd gRer-omconevderisaiotne, dwhgene creoll cgoronwvthe crosntiionune,s awbehrreanntlyc aefltelr gthreo wthcontinuesaberrantlyafterthe
cell cycle is blocked in response to severe stress and damage. In comparison, quiescence-origin se-
nceesclelnccey ocrilgeinaitses bfrolomc qkuieesdcenitn celrlse vsipa qouniessceentceo deseepveneinrge, ascctormepsasnieadn bdy ad praomgreassgiveel.y Incomparison, quiescence-origin
increasing Rb–E2F switch threshold in response to decreased lysosomal autophagy and increased
RsOeSn aecscucmeunlacteiono arnidg pinroatetien sagfgrroegmatioqn.u Sieensescceennt tceclles lalrse ivrrieaverqsiubliye asrcreesntedc eunddeere pphyesnioi-ng,accompaniedbyaprogressively
liongiccarle caonsdinitigonRs. bDe–eEp 2quFiesscwenitt ccehlls tahrer reesvehrsoibldle biunt rreeqsupireo sntrsonegteor gdroewcthr estaimseuldatiloyn saonds omalautophagyandincreasedROS
take a longer time to re-enter the cell cycle than shallow quiescent cells. The boundary between very
daecepc uqumiesucelnacet iaondn qauinesdcenpcer-oortiegiinn seangesgcerneceg (athtei orend .daSsheend elisnce)e isn btlucrereldl.s areirreversiblyarrestedunderphysiological
Fcuondnidngi:t Tihoisn rses.eaDrceh ewpas qpaurtiiaellsyc seupnptorcteedl lbsy tahre eRerseeavrcehr Dseivbelloepmbeuntt Grreanqt uofi trhee Usntrivoern-gergrowthstimulationandtakea
sity of Arizona.
longertimetore-enterthecellcyclethanshallowquiescentcells.Theboundarybetweenverydeep
Conflicts of Interest: The authors declare no conflicts of interest. The funders had no role in the
dqeusigine sofc tehen sctuedya;n ind thqe cuoilleecstcioenn, acneal-yosers,i gori inntesreprneteastiocne onf cdeata(;t ihn ether wedritidnga osf hthee dmalniun-e)isblurred.
script; or in the decision to publish the results.
Epigeneticregulationplaysacrucialroleinproliferation-originsenescence,including
References
1. Hayflick, L.; Moorhead, P.S.t Thhee sefroiarl cmultaivtaitioonn ofo hfumsaenn deipslocide cnelcl estr-aainsss. Eoxcp.i Caetlle Rdes. h19e61t, e25r,o 58c5h–6r2o1. matinfoci(SAHF)thatrepressE2Ftarget
2. Kuilman, T.; Michaloglou, C.; Mooi, W.J.; Peeper, D.S. The essence of senescence. Genes Dev. 2010, 24, 2463–2479.
genes [78] and changes in DNA methylation and histone modification patterns[79,80].
3. Rodier, F.; Campisi, J. Four faces of cellular senescence. J. Cell Biol. 2011, 192, 547–556.
4. Campisi, J.; di Fagagna, F.DE. Cpelliuglaer nseenetsiccencme: Wechehna bnadi tshmingss haaprpeena tlos gooodin cevllso. Nlvate. Rdev.i Mnolq. Cuelil eBisolc. 2e0n07c, 8e, 7d29e–epeningandtransitiontosenes-
740.
5. Munoz-Espin, D.; Serrano, Mc.e Cnelcluela,r saesnessceenecne: Firnomt phheysiRoloOgyS to- mpatehodloigayt. eNdat. Rdeve. rMeopl. Creells Bsioilo. 2n014o, 1f5,t 4h82e–4p961. 6locus[18]andtheroleofketone
6. Gorgoulis, V.; Adams, P.D.; Alimonti, A.; Bennett, D.C.; Bischof, O.; Bishop, C.; Campisi, J.; Collado, M.; Evangelou, K.;
body-mediatedacetylationandactivationofthep53locus[69]inMuSCsaswellasthe
Ferbeyre, G.; et al. Cellular Senescence: Defining a Path Forward. Cell 2019, 179, 813–827.
7. Lanz, M.C.; Zatulovskiy, E.;l Sownafgfer-,o Mb.Ps.; eZrhvaneg,d L.;i Inlercterne, aI.;s Zehainng, Sc.;h Yrouo, mD.Sa.; tMianrincoov, nGd.; MecnAslpaintei, oP.n; Eliians, dJ.Ee.; eetp quiescentcells[37]. However,
al. Increasing cell size remodels the proteome and promotes senescence. Mol. Cell 2022, 82, 3255–3269.e8.
8. Coller, H.A.; Sang, L.; Roberats, cJ.Mo.m A Nperwe Dhesecnripstiiovn eof Cuenlludlare Qrusitesacenndce.i PnLgoS Boiofl. t20h06e, 4e, ep83i. geneticlandscapechangesduringquiescence
9. Marescal, O.; Cheeseman, I.M. Cellular Mechanisms and Regulation of Quiescence. Dev. Cell 2020, 55, 259–271.
deepening and the quiescence-to-senescence transition is still lacking, highlighting an
10. Cheung, T.H.; Rando, T.A. Molecular regulation of stem cell quiescence. Nat. Rev. Mol. Cell Biol. 2013, 14, 329–340.
11. Blagosklonny, M.V. Geroconivmerspioon: rIrtraevnertsibaler seteap tfoo crellufulart suenreescerneces. eCeallr Ccyhcle 2[04104, ]1.3, 3628–3635.
12. Sang, L.; Coller, H.A. Fear of commitment: Hes1 protects quiescent fibroblasts from irreversible cellular fates. Cell Cycle 2009, 8,
2161–2167. Theheterogeneityandcontextdependencyofthequiescence-to-senescencetransition
13. Sousa-Victor, P.; Gutarra, S.; García-Prat, L.; Rodriguez-Ubreva, J.; Ortet, L.; Ruiz-Bonilla, V.; Jardí, M.; Ballestar, E.; González,
arealsoapparent,underscoringthecomplexityofthesecellularprocesses. Forinstance,
S.; Serrano, A.L.; et al. Geriatric muscle stem cells switch reversible quiescence into senescence. Nature 2014, 506, 316–321.
ROS-mediatedp16INK4aactivationoccursthroughepigeneticderepressioninMuSCs[18]
butviap38MAPKhyperactivationinHSPCs[14].Blockingp16INK4aactivationpreventsthe
quiescence-to-senescencetransitiononlyinasubsetofcells[13],suggestingtheinvolvement
of other molecular effectors driving the quiescence-origin senescence. Furthermore, is
lysosomalautophagyalwaystheprimarytriggerforquiescencedeepeningandtransition
tosenescence,anddoesthisprocessalwaysconvergeontotheRb–E2Fswitchthreshold—or
possiblyregulatedownstreamswitchescontrollingSphaseentry[67,68]ordownstream
E2Ftargetgenesnecessaryforcellproliferation[41,78]? Growingcellsexitingfromeither
theG1orG2phaseofthecellcycleconvergeontothesamesenescentstatewithaG1-like
molecularsignature[76]. Howaboutquiescence-originsenescence? Whatareitsmolecular
markers,andtowhatextentdotheyoverlapwithordifferfromthemarkersofproliferation-
origin senescence, beyond the sustained (if not totally irreversible) arrested phenotype
(Figure1)? Futureinvestigationsareneededtofindtheanswers.
4. Conclusions
Unlike conventional proliferation-origin senescence, quiescence-origin senescence
involvesthedirecttransitionofquiescentcellstosenescence. Itrepresentsapreviously
understudiednewtypeofcellularagingprocess(Figure1). Giventhatthevastmajorityof
cellsinthehumanbodyareinquiescence,notinproliferation,quiescence-originsenescence
Biomedicines2024,12,1837 6of8
isexpectedtoberesponsibleforalargerproportionofirreversiblyarrestedsenescentcells
inourtissuesthanpreviouslyrealized.
Understandingthemechanismsunderlyingthecontinuumofquiescence-to-senescence
transitionthroughquiescencedeepeninghasimportantimplicationsformultipleareasof
biomedicalresearchandclinicalpractice,suchascancerbiology,aging,andregenerative
medicine. Future research will reveal both common and cell type-specific mechanisms
ofquiescence-depthregulationandtransitiontosenescence,identifyspecificmolecular
markers,andsuggesttheoptimalstrategiestotargetthisgroupofpreviouslyoverlooked
senescentcellstoreshapeourapproachestopromotinghealthandlongevity.
Funding:ThisresearchwaspartiallysupportedbytheResearchDevelopmentGrantoftheUniversity
ofArizona.
ConflictsofInterest:Theauthorsdeclarenoconflictsofinterest.Thefundershadnoroleinthedesign
ofthestudy;inthecollection,analyses,orinterpretationofdata;inthewritingofthemanuscript;or
inthedecisiontopublishtheresults.
References
1. Hayflick,L.;Moorhead,P.S.Theserialcultivationofhumandiploidcellstrains.Exp.CellRes.1961,25,585–621.[CrossRef]
2. Kuilman,T.;Michaloglou,C.;Mooi,W.J.;Peeper,D.S.Theessenceofsenescence.GenesDev.2010,24,2463–2479.[CrossRef]
3. Rodier,F.;Campisi,J.Fourfacesofcellularsenescence.J.CellBiol.2011,192,547–556.[CrossRef]
4. Campisi,J.;diFagagna,F.D.Cellularsenescence:Whenbadthingshappentogoodcells.Nat.Rev.Mol.CellBiol.2007,8,729–740.
[CrossRef]
5. Munoz-Espin,D.;Serrano,M.Cellularsenescence: Fromphysiologytopathology. Nat. Rev. Mol. CellBiol. 2014,15,482–496.
[CrossRef]
6. Gorgoulis, V.; Adams, P.D.; Alimonti, A.; Bennett, D.C.; Bischof, O.; Bishop, C.; Campisi, J.; Collado, M.; Evangelou, K.;
Ferbeyre,G.;etal.CellularSenescence:DefiningaPathForward.Cell2019,179,813–827.[CrossRef]
7. Lanz,M.C.;Zatulovskiy,E.;Swaffer,M.P.;Zhang,L.;Ilerten,I.;Zhang,S.;You,D.S.;Marinov,G.;McAlpine,P.;Elias,J.E.;etal.
Increasingcellsizeremodelstheproteomeandpromotessenescence.Mol.Cell2022,82,3255–3269.e8.[CrossRef]
8. Coller,H.A.;Sang,L.;Roberts,J.M.ANewDescriptionofCellularQuiescence.PLoSBiol.2006,4,e83.[CrossRef]
9. Marescal,O.; Cheeseman,I.M.CellularMechanismsandRegulationofQuiescence. Dev. Cell2020,55,259–271. [CrossRef]
[PubMed]
10. Cheung,T.H.;Rando,T.A.Molecularregulationofstemcellquiescence.Nat.Rev.Mol.CellBiol.2013,14,329–340.[CrossRef]
11. Blagosklonny,M.V.Geroconversion:Irreversiblesteptocellularsenescence.CellCycle2014,13,3628–3635.[CrossRef]
12. Sang,L.;Coller,H.A.Fearofcommitment:Hes1protectsquiescentfibroblastsfromirreversiblecellularfates.CellCycle2009,8,
2161–2167.[CrossRef]
13. Sousa-Victor,P.;Gutarra,S.;García-Prat,L.;Rodriguez-Ubreva,J.;Ortet,L.;Ruiz-Bonilla,V.;Jardí,M.;Ballestar,E.;González,S.;
Serrano,A.L.;etal.Geriatricmusclestemcellsswitchreversiblequiescenceintosenescence.Nature2014,506,316–321.[CrossRef]
14. Cho,J.;Yusuf,R.;Kook,S.;Attar,E.;Lee,D.;Park,B.;Cheng,T.;Scadden,D.T.;Lee,B.C.PurinergicP2Y(1)(4)receptormodulates
stress-inducedhematopoieticstem/progenitorcellsenescence.J.Clin.Investig.2014,124,3159–3171.[CrossRef]
15. Marthandan,S.;Priebe,S.;Hemmerich,P.;Klement,K.;Diekmann,S.Long-termquiescentfibroblastcellstransitintosenescence.
PLoSONE2014,9,e115597.[CrossRef]
16. Fujimaki,K.;Li,R.;Chen,H.;DellaCroce,K.;Zhang,H.H.;Xing,J.;Bai,F.;Yao,G.Gradedregulationofcellularquiescence
depthbetweenproliferationandsenescencebyalysosomaldimmerswitch.Proc.Natl.Acad.Sci.USA2019,116,22624–22634.
[CrossRef]
17. Sender,R.;Milo,R.Thedistributionofcellularturnoverinthehumanbody.Nat.Med.2021,27,45–48.[CrossRef]
18. García-Prat,L.;Martínez-Vicente,M.;Perdiguero,E.;Ortet,L.;Rodríguez-Ubreva,J.;Rebollo,E.;Ruiz-Bonilla,V.;Gutarra,S.;
Ballestar,E.;Serrano,A.L.;etal.Autophagymaintainsstemnessbypreventingsenescence.Nature2016,529,37–42.[CrossRef]
19. Bucher,N.L.RegenerationofMammalianLiver.Int.Rev.Cytol.1963,15,245–300.
20. Adelman,R.C.;Stein,G.;Roth,G.S.;Englander,D.Age-dependentregulationofmammalianDNAsynthesisandcellproliferation
Invivo.Mech.AgeingDev.1972,1,49–59.[CrossRef]
21. Gunther,G.R.;Wang,J.L.;Edelman,G.M.Thekineticsofcellularcommitmentduringstimulationoflymphocytesbylectins.
J.CellBiol.1974,62,366–377.[CrossRef]
22. Augenlicht,L.H.;Baserga,R.ChangesintheG0stateofWI-38fibroblastsatdifferenttimesafterconfluence.Exp.CellRes.1974,
89,255–262.[CrossRef]
23. Martin,R.G.;Stein,S.Restingstateinnormalandsimianvirus40transformedChinesehamsterlungcells.Proc.Natl.Acad.Sci.
USA1976,73,1655–1659.[CrossRef]
24. Owen,T.A.;Soprano,D.R.;Soprano,K.J.AnalysisofthegrowthfactorrequirementsforstimulationofWI-38cellsafterextended
periodsofdensity-dependentgrowtharrest.J.Cell.Physiol.1989,139,424–431.[CrossRef]
Biomedicines2024,12,1837 7of8
25. Yanez,I.;O’Farrell,M.Variationinthelengthofthelagphasefollowingserumrestimulationofmouse3T3cells.CellBiol.Int.
Rep.1989,13,453–462.[CrossRef]
26. Lum,J.J.;Bauer,D.E.;Kong,M.;Harris,M.H.;Li,C.;Lindsten,T.;Thompson,C.B.Growthfactorregulationofautophagyandcell
survivalintheabsenceofapoptosis.Cell2005,120,237–248.[CrossRef]
27. Yao,G.Modellingmammaliancellularquiescence.InterfaceFocus2014,4,20130074.[CrossRef]
28. Kwon,J.S.;Everetts,N.J.;Wang,X.;Wang,W.;DellaCroce,K.;Xing,J.;Yao,G.ControllingDepthofCellularQuiescencebyan
Rb-E2FNetworkSwitch.CellRep.2017,20,3223–3235.[CrossRef]
29. Gookin,S.;Min,M.;Phadke,H.;Chung,M.;Moser,J.;Miller,I.;Carter,D.;Spencer,S.L.Amapofproteindynamicsduring
cell-cycleprogressionandcell-cycleexit.PLoSBiol.2017,15,e2003268.[CrossRef]
30. vanVelthoven,C.T.J.; Rando,T.A.StemCellQuiescence: Dynamism,Restraint,andCellularIdling. CellStemCell2019,24,
213–225.[CrossRef]
31. Audesse,A.J.;Webb,A.E.Mechanismsofenhancedquiescenceinneuralstemcellaging.Mech.AgeingDev.2020,191,111323.
[CrossRef][PubMed]
32. Harris, L.; Rigo, P.; Stiehl, T.; Gaber, Z.B.; Austin, S.H.; Masdeu, M.d.M.; Edwards, A.; Urbán, N.; Marciniak-Czochra, A.;
Guillemot,F.Coordinatedchangesincellularbehaviorensurethelifelongmaintenanceofthehippocampalstemcellpopulation.
CellStemCell2021,28,863–876.e6.[CrossRef][PubMed]
33. Ibrayeva,A.;Bay,M.;Pu,E.;Jörg,D.J.;Peng,L.;Jun,H.;Zhang,N.;Aaron,D.;Lin,C.;Resler,G.;etal.Earlystemcellaginginthe
maturebrain.CellStemCell2021,28,955–966.e7.[CrossRef][PubMed]
34. Laporte,D.;Jimenez,L.;Gouleme,L.;Sagot,I.Yeastquiescenceexitswiftnessisinfluencedbycellvolumeandchronologicalage.
Microb.Cell2017,5,104–111.[CrossRef][PubMed]
35. Olmedo,M.;Mata-Cabana,A.;Rodríguez-Palero,M.J.;García-Sánchez,S.;Fernández-Yañez,A.;Merrow,M.;Artal-Sanz,M.
Prolongedquiescencedelayssomaticstemcell-likedivisionsinCaenorhabditiselegansandiscontrolledbyinsulinsignaling.
AgingCell2020,19,e13085.[CrossRef][PubMed]
36. Darzynkiewicz,Z.;Traganos,F.;Melamed,M.R.Newcellcyclecompartmentsidentifiedbymultiparameterflowcytometry.
Cytometry1980,1,98–108.[CrossRef][PubMed]
37. Rossini,M.;Lin,J.C.;Baserga,R.EffectsofprolongedquiescenceonneucleiandchromatinofWI-38fibroblasts.J.Cell.Physiol.
1976,88,1–11.[CrossRef][PubMed]
38. Soprano,K.J.WI-38celllong-termquiescencemodelsystem:Avaluabletooltostudymoleculareventsthatregulategrowth.
J.Cell.Biochem.1994,54,405–414.[CrossRef]
39. Valcourt, J.R.; Lemons, J.M.; Haley, E.M.; Kojima, M.; Demuren, O.O.; Coller, H.A.Stayingalive: Metabolicadaptationsto
quiescence.CellCycle2012,11,1680–1696.[CrossRef]
40. Bonitto,K.;Sarathy,K.;Atai,K.;Mitra,M.;Coller,H.A.IsThereaHistoneCodeforCellularQuiescence?Front.CellDev.Biol.
2021,9,739780.[CrossRef]
41. Fujimaki,K.;Yao,G.Celldormancyplasticity:Quiescencedeepensintosenescencethroughadimmerswitch.Physiol.Genom.
2020,52,558–562.[CrossRef]
42. Rodgers,J.T.;King,K.Y.;Brett,J.O.;Cromie,M.J.;Charville,G.W.;Maguire,K.K.;Brunson,C.;Mastey,N.;Liu,L.;Tsai,C.-R.;etal.
mTORC1controlstheadaptivetransitionofquiescentstemcellsfromG0toG(Alert). Nature2014,510,393–396. [CrossRef]
[PubMed]
43. Llorens-Bobadilla,E.;Zhao,S.;Baser,A.;Saiz-Castro,G.;Zwadlo,K.;Martin-Villalba,A.Single-CellTranscriptomicsRevealsa
PopulationofDormantNeuralStemCellsthatBecomeActivateduponBrainInjury.CellStemCell2015,17,329–340.[CrossRef]
44. Rodgers,J.T.;Schroeder,M.D.;Ma,C.;Rando,T.A.HGFAIsanInjury-RegulatedSystemicFactorthatInducestheTransitionof
StemCellsintoGAlert.CellRep.2017,19,479–486.[CrossRef]
45. Lee,G.;EspiritoSanto,A.I.;Zwingenberger,S.;Cai,L.;Vogl,T.;Feldmann,M.;Horwood,N.J.;Chan,J.K.;Nanchahal,J.Fully
reducedHMGB1acceleratestheregenerationofmultipletissuesbytransitioningstemcellstoGAlert.Proc.Natl.Acad.Sci.USA
2018,115,E4463–E4472.
46. Baker,D.J.;Sedivy,J.M.Probingthedepthsofcellularsenescence.J.CellBiol.2013,202,11–13.[CrossRef]
47. VanDeursen,J.M.Theroleofsenescentcellsinageing.Nature2014,509,439–446.[CrossRef]
48. Zhang,X.;Liu,X.;Du,Z.;Wei,L.;Fang,H.;Dong,Q.;Niu,J.;Li,Y.;Gao,J.;Zhang,M.Q.;etal. Thelossofheterochromatin
isassociatedwithmultiscalethree-dimensionalgenomereorganizationandaberranttranscriptionduringcellularsenescence.
GenomeRes.2021,31,1121–1135.[CrossRef]
49. Hernandez-Segura,A.;deJong,T.V.;Melov,S.;Guryev,V.;Campisi,J.;DeMaria,M.UnmaskingTranscriptionalHeterogeneityin
SenescentCells.Curr.Biol.2017,27,2652–2660.e4.[CrossRef][PubMed]
50. Wei,M.Y.;Yao,G.ModelingtheDepthofCellularDormancyfromRNA-SequencingData.MethodsMol.Biol.2024,2811,123–135.
[PubMed]
51. Urban,N.;Cheung,T.H.Stemcellquiescence:Thechallengingpathtoactivation.Development2021,148,dev165084.[CrossRef]
[PubMed]
52. Brooks,R.F.CellCycleCommitmentandtheOriginsofCellCycleVariability.Front.CellDev.Biol.2021,9,698066.[CrossRef]
[PubMed]
Biomedicines2024,12,1837 8of8
53. Truskowski,K.;Amend,S.R.;Pienta,K.J.Dormantcancercells:Programmedquiescence,senescence,orboth?CancerMetastasis
Rev.2023,42,37–47.[CrossRef][PubMed]
54. Wiecek,A.J.;Cutty,S.J.;Kornai,D.;Parreno-Centeno,M.;Gourmet,L.E.;Tagliazucchi,G.M.;Jacobson,D.H.;Zhang,P.;Xiong,L.;
Bond,G.L.;etal.GenomichallmarksandtherapeuticimplicationsofG0cellcyclearrestincancer.GenomeBiol.2023,24,128.
[CrossRef]
55. Tanke, N.T.; Liu, Z.; Gore, M.T.; Bougaran, P.; Linares, M.B.; Marvin, A.; Sharma, A.; Oatley, M.; Yu, T.; Quigley, K.; et al.
EndothelialCellFlow-MediatedQuiescenceIsTemporallyRegulatedandUtilizestheCellCycleInhibitorp27.Arter.Thromb.
Vasc.Biol.2024,44,1265–1282.[CrossRef][PubMed]
56. Ashraf,H.M.;Fernandez,B.;Spencer,S.L.Theintensitiesofcanonicalsenescencebiomarkersintegratethedurationofcell-cycle
withdrawal.Nat.Commun.2023,14,4527.[CrossRef][PubMed]
57. deMagalhaes,J.P.Cellularsenescenceinnormalphysiology.Science2024,384,1300–1301.[CrossRef][PubMed]
58. Leeman,D.S.;Hebestreit,K.;Ruetz,T.;Webb,A.E.;McKay,A.;Pollina,E.A.;Dulken,B.W.;Zhao,X.;Yeo,R.W.;Ho,T.T.;etal.
Lysosome activation clears aggregates and enhances quiescent neural stem cell activation during aging. Science 2018, 359,
1277–1283.[CrossRef][PubMed]
59. Dyson,N.TheregulationofE2FbypRB-familyproteins.GenesDev.1998,12,2245–2262.[CrossRef]
60. Nevins,J.R.TheRb/E2Fpathwayandcancer.Hum.Mol.Genet.2001,10,699–703.[CrossRef]
61. Sears, R.C.; Nevins, J.R. Signaling networks that link cell proliferation and cell fate. J. Biol. Chem. 2002, 277, 11617–11620.
[CrossRef]
62. Trimarchi,J.M.;Lees,J.A.SiblingrivalryintheE2Ffamily.Nat.Rev.Mol.CellBiol.2002,3,11–20.[CrossRef][PubMed]
63. Polager,S.;Ginsberg,D.E2F-atthecrossroadsoflifeanddeath.TrendsCellBiol.2008,18,528–535.[CrossRef][PubMed]
64. Yao,G.;Lee,T.J.;Mori,S.;Nevins,J.R.;You,L.AbistableRb-E2Fswitchunderliestherestrictionpoint.Nat.CellBiol.2008,10,
476–482.[CrossRef][PubMed]
65. Yao,G.;Tan,C.;West,M.;Nevins,J.R.;You,L.Originofbistabilityunderlyingmammaliancellcycleentry.Mol.Syst.Biol.2011,
7,485.[CrossRef][PubMed]
66. Wang,X.;Fujimaki,K.;Mitchell,G.C.;Kwon,J.S.;DellaCroce,K.;Langsdorf,C.;Zhang,H.H.;Yao,G.Exitfromquiescence
displaysamemoryofcellgrowthanddivision.Nat.Commun.2017,8,321.[CrossRef][PubMed]
67. Cappell,S.D.;Chung,M.;Jaimovich,A.;Spencer,S.L.;Meyer,T.IrreversibleAPC(Cdh1)InactivationUnderliesthePointofNo
ReturnforCell-CycleEntry.Cell2016,166,167–180.[CrossRef][PubMed]
68. Cappell,S.D.;Mark,K.G.;Garbett,D.;Pack,L.R.;Rape,M.;Meyer,T.EMI1switchesfrombeingasubstratetoaninhibitorof
APC/C(CDH1)tostartthecellcycle.Nature2018,558,313–317.[CrossRef][PubMed]
69. Benjamin,D.I.;Both,P.;Benjamin,J.S.;Nutter,C.W.;Tan,J.H.;Kang,J.;Machado,L.A.;Klein,J.D.;deMorree,A.;Kim,S.;etal.
Fastinginducesahighlyresilientdeepquiescentstateinmusclestemcellsviaketonebodysignaling. CellMetab. 2022,34,
902–918.e6.[CrossRef]
70. Shay,J.W.;Pereira-Smith,O.M.;Wright,W.E.AroleforbothRBandp53intheregulationofhumancellularsenescence.Exp.Cell
Res.1991,196,33–39.[CrossRef]
71. Beauséjour,C.M.;Krtolica,A.;Galimi,F.;Narita,M.;Lowe,S.W.;Yaswen,P.;Campisi,J.Reversalofhumancellularsenescence:
Rolesofthep53andp16pathways.EMBOJ.2003,22,4212–4222.[CrossRef][PubMed]
72. Sage,J.;Miller,A.L.;Perez-Mancera,P.A.;Wysocki,J.M.;Jacks,T.Acutemutationofretinoblastomagenefunctionissufficientfor
cellcyclere-entry.Nature2003,424,223–228.[CrossRef][PubMed]
73. Dirac,A.M.;Bernards,R.Reversalofsenescenceinmousefibroblaststhroughlentiviralsuppressionofp53.J.Biol.Chem.2003,
278,11731–11734.[CrossRef][PubMed]
74. Pajalunga,D.;Mazzola,A.;Salzano,A.M.;Biferi,M.G.;DeLuca,G.;Crescenzi,M.Criticalrequirementforcellcycleinhibitorsin
sustainingnonproliferativestates.J.CellBiol.2007,176,807–818.[CrossRef][PubMed]
75. Reyes,J.;Chen,J.-Y.;Stewart-Ornstein,J.;Karhohs,K.W.;Mock,C.S.;Lahav,G.Fluctuationsinp53SignalingAllowEscapefrom
Cell-CycleArrest.Mol.Cell2018,71,581–591.e5.[CrossRef][PubMed]
76. Stallaert,W.;Taylor,S.R.;Kedziora,K.M.;Taylor,C.D.;Sobon,H.K.;Young,C.L.;Limas,J.C.;Holloway,J.V.;Johnson,M.S.;
Cook,J.G.;etal.Themoleculararchitectureofcellcyclearrest.Mol.Syst.Biol.2022,18,e11087.[CrossRef][PubMed]
77. Blagosklonny, M.V.Rapamycin, proliferationandgeroconversiontosenescence. CellCycle2018, 17, 2655–2665. [CrossRef]
[PubMed]
78. Narita,M.;Nuñez,S.;Heard,E.;Lin,A.W.;Hearn,S.A.;Spector,D.L.;Hannon,G.J.;Lowe,S.W.Rb-MediatedHeterochromatin
FormationandSilencingofE2FTargetGenesduringCellularSenescence.Cell2003,113,703–716.[CrossRef][PubMed]
79. Crouch,J.;Shvedova,M.;Thanapaul,R.;Botchkarev,V.;Roh,D.EpigeneticRegulationofCellularSenescence.Cells2022,11,672.
[CrossRef]
80. Paluvai,H.;DiGiorgio,E.;Brancolini,C.TheHistoneCodeofSenescence.Cells2020,9,466.[CrossRef]
Disclaimer/Publisher’sNote: Thestatements, opinionsanddatacontainedinallpublicationsaresolelythoseoftheindividual
author(s)andcontributor(s)andnotofMDPIand/ortheeditor(s).MDPIand/ortheeditor(s)disclaimresponsibilityforanyinjuryto
peopleorpropertyresultingfromanyideas,methods,instructionsorproductsreferredtointhecontent.
